Marketing localization

In today’s interconnected economy, the difference between companies that thrive globally and those that struggle often comes down to one critical factor: how they approach language strategy and localization planning. While many organizations still rely on intuition or outdated market assumptions, forward-thinking companies are embracing a fundamentally different approach—one powered by data, precision, and strategic insight. 

As large language models (LLMs) like GPT redefine how we translate and communicate across borders, one persistent issue remains: AI still struggles with South Slavic languages — especially Croatian, Serbian, Bosnian, and Slovenian. 

In today’s digital age, the landscape of language services has undergone a dramatic transformation. With the advent of free translation tools, many wonder about the future of language service providers (LSPs). At Ciklopea, we’re not only adapting to these changes, but have evolved to offer unparalleled value in this new ecosystem.

For almost 200 years, Dun & Bradstreet has helped clients and partners grow and thrive through the power of data, analytics, and data-driven solutions. Their marketing manager Izabela Berlengi kindly shares their experience of working with Ciklopea.

Cars. They are complex, sophisticated and ubiquitous. Their build quality and safety features are extremely important in our everyday lives. Yet, much of what we need to know when purchasing a car is contained in its brand – luxurious, family, sport cars, SUVs (and more) are all safely tucked in the brand names whose reputation has been carefully developed for decades. And it is probably true that for most of these decades, the localization requirements of the automotive industry were mostly limited to marketing materials and user manuals. But all things change.

Transcreation is most definitely not one of the things that spring to mind when we talk about the medical translation or localization of pharmaceutical materials. With all the seriousness of study protocols, summaries of product characteristics and correspondences with the regulatory bodies, we tend to forget that medical and pharmaceutical companies also need marketing solutions to propel their business and reach their customers and clients.